Wells Fargo & Company Forecasts Strong Price Appreciation for Globe Life (NYSE:GL) Stock

Globe Life (NYSE:GL) had its price target increased by equities research analysts at Wells Fargo & Company from $170.00 to $171.00 in a research report issued on Wednesday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Wells Fargo & Company‘s price target indicates a potential upside of 17.08% from the company’s previous close.

GL has been the subject of a number of other research reports. Truist Financial lifted their target price on shares of Globe Life from $158.00 to $180.00 and gave the stock a “buy” rating in a research report on Friday, February 6th. Weiss Ratings upgraded Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Friday, February 13th. Evercore set a $157.00 target price on Globe Life in a report on Wednesday, February 18th. Piper Sandler reissued an “overweight” rating and set a $167.00 price target on shares of Globe Life in a research report on Friday, November 21st. Finally, Morgan Stanley restated an “overweight” rating and issued a $176.00 price objective on shares of Globe Life in a research report on Monday, December 15th. Eight research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $171.33.

Globe Life Stock Up 1.3%

GL opened at $146.06 on Wednesday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.07 and a current ratio of 0.07. The company has a market cap of $11.63 billion, a price-to-earnings ratio of 10.37 and a beta of 0.47. Globe Life has a one year low of $109.38 and a one year high of $152.71. The business’s fifty day moving average is $141.76 and its two-hundred day moving average is $138.69.

Globe Life (NYSE:GL) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). Globe Life had a net margin of 19.37% and a return on equity of 21.75%. The firm had revenue of $1.52 billion during the quarter, compared to analysts’ expectations of $1.53 billion. During the same quarter in the prior year, the business earned $3.14 EPS. The company’s quarterly revenue was up 3.6% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. Analysts anticipate that Globe Life will post 13.87 EPS for the current fiscal year.

Insiders Place Their Bets

In other Globe Life news, CEO Frank M. Svoboda sold 12,500 shares of Globe Life stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $144.78, for a total value of $1,809,750.00. Following the completion of the sale, the chief executive officer owned 35,868 shares in the company, valued at $5,192,969.04. The trade was a 25.84% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CMO Jennifer Allison Haworth sold 10,000 shares of the stock in a transaction dated Thursday, February 12th. The stock was sold at an average price of $143.14, for a total transaction of $1,431,400.00. Following the transaction, the chief marketing officer owned 17,479 shares in the company, valued at approximately $2,501,944.06. The trade was a 36.39% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 63,629 shares of company stock worth $9,223,785 in the last three months. Company insiders own 1.51% of the company’s stock.

Hedge Funds Weigh In On Globe Life

Several institutional investors and hedge funds have recently bought and sold shares of GL. Compound Planning Inc. boosted its holdings in shares of Globe Life by 4.3% in the 4th quarter. Compound Planning Inc. now owns 1,968 shares of the company’s stock valued at $275,000 after purchasing an additional 82 shares during the last quarter. Transcend Capital Advisors LLC raised its position in shares of Globe Life by 3.9% in the 4th quarter. Transcend Capital Advisors LLC now owns 2,265 shares of the company’s stock worth $317,000 after buying an additional 84 shares during the period. Natural Investments LLC boosted its holdings in Globe Life by 2.6% in the fourth quarter. Natural Investments LLC now owns 3,452 shares of the company’s stock valued at $482,000 after acquiring an additional 87 shares during the last quarter. Parallel Advisors LLC grew its position in Globe Life by 5.6% during the fourth quarter. Parallel Advisors LLC now owns 1,651 shares of the company’s stock valued at $231,000 after acquiring an additional 87 shares during the period. Finally, Intech Investment Management LLC grew its position in Globe Life by 0.8% during the second quarter. Intech Investment Management LLC now owns 11,572 shares of the company’s stock valued at $1,438,000 after acquiring an additional 95 shares during the period. Institutional investors and hedge funds own 81.61% of the company’s stock.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.